Milan - Delayed Quote • EUR (S34123.MI) Follow Compare 0.2905 -0.1015 (-25.89%) At close: August 2 at 9:39 PM GMT+2 Related News Starbucks looks like a shell of its former glory: Morning Brief It's shocking to see the downward trajectory of this iconic coffee institution. Stocks look to rebound during quieter week for economic data: What to know this week A quiet economic data week greets a slumping stock market as investors are increasingly concerned about the impact of high interest rates on the US economy. 72% of Warren Buffett's Berkshire Hathaway Portfolio Is Invested in These 5 Dividend Stocks Yes, Buffett loves dividends. Meet the 5.4%-Yielding Dividend Stock That Is Crushing the S&P 500 and Nasdaq Composite in 2024 Kinder Morgan's investment thesis is noticeably improving in the age of AI. Forget Nvidia: Billionaires Are Buying Up This Artificial Intelligence (AI) Stock Instead Learn the hidden AI play that billionaires can't get enough of. Kinder Morgan, Inc.'s (NYSE:KMI) institutional investors lost 3.2% over the past week but have profited from longer-term gains Key Insights Significantly high institutional ownership implies Kinder Morgan's stock price is sensitive to their... Mobileye Stock Crashed After Earnings. Is It a Buy? The next few quarters will clearly be rough for Mobileye. But after that? What To Expect in the Markets This Week Coming Up: Services Sector Data and Earnings from Eli Lilly, Disney, Uber, Palantir, and More History Says the Nasdaq Could Soar: 3 Warren Buffett Stocks to Buy Now These outstanding businesses are worth buying hand over fist right now. Missed Out on Palantir's Run-Up? Here's My Best Alternative Data Software Stock to Buy and Hold After Palantir's outsized success over the past 18 months, there's a better buying opportunity today. Investing $100,000 in These 7 High-Yield Dividend Stocks Could Generate Over $7,000 in Annual Passive Income Making passive income should be easy with these great stocks. Eli Lilly's Obesity Drug Shows a Heart Benefit. Is It Time to Buy? Recent results from a clinical trial show that treatment with Zepbound significantly reduced patients' risk of heart failure outcomes, including cardiovascular death. 2 Nasdaq Stocks to Buy Before They Soar as Much as 226% According to Select Wall Street Analysts The tech-centric index is taking a break from its relentless run, but some stocks in the Nasdaq have much further to climb, according to Wall Street. Consistent Enterprise Product Partners Looks Ready to Kick Growth Up a Notch Why this is good news for investors. Berkshire Hathaway Added 26 Million Shares of This Stock in the Past 3 Quarters: Here's Why It's a Smart Buy Today Berkshire Hathaway has a $7.2 billion stake in this insurance titan. 1 Unstoppable Stock That Could Join Apple, Microsoft, Nvidia, Alphabet, Amazon, and Meta in the $1 Trillion Club A long track record of success could help drive this artificial intelligence (AI) hardware specialist to new heights. Invest $50K in Johnson & Johnson to Become a Dividend Millionaire in 10 Years Warren Buffett, one of the most successful dividend investors in history, owes much of his financial success to a simple yet powerful strategy: dividend reinvestment programs (DRIP). This approach leverages the power of compounding by reinvesting ... 2 Ultra-High-Yield Dividend Stocks to Buy in August and Hold at Least a Decade With an average yield above 7% at recent prices, these stocks could give your passive income stream a big boost. Coca-Cola vs. PepsiCo: Which Stock Is Better for Dividend Investors? There are a lot of similarities between these two stocks, and picking the better investment may not be as easy as you'd think. Is the U.S. Flashing a Big Warning Sign for Coca-Cola and PepsiCo? PepsiCo and Coca-Cola both had weak showings in the place they call home. It could be a bad sign for the future.
